These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6187447)

  • 21. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
    Matsumoto M; Weckbecker G; Cory JG
    Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS; Yu J; Yu AL
    J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyadenosine induced G1 phase arrest in leukemic T cells.
    Fox RM; Tripp EH; Taylor IW
    Adv Exp Med Biol; 1984; 165 Pt B():333-8. PubMed ID: 6609539
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
    Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
    Callard RE; Ewing TM; Fox RM
    Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
    Overgaard-Hansen K; Klenow H
    J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
    Szabados E; Duggleby RG; Christopherson RI
    Int J Biochem Cell Biol; 1996 Dec; 28(12):1405-15. PubMed ID: 9022297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nuclear and cytoplasmic poly A-containing RNA in normal and leukemic human leukocytes].
    Blinov MN; Vladimirova AD; Luganova IS
    Vopr Onkol; 1978; 24(10):23-7. PubMed ID: 716312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes.
    Kefford RF; Helmer MA; Fox RM
    Cancer Res; 1982 Sep; 42(9):3822-7. PubMed ID: 6980705
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of polyadenylated mRNA in growing human lymphocytes.
    Berger SL; Birkenmeier CS
    Biochim Biophys Acta; 1979 Mar; 562(1):80-91. PubMed ID: 312113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency.
    Waddell D; Ullman B
    J Biol Chem; 1983 Apr; 258(7):4226-31. PubMed ID: 6339493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polyadenylated RNA and poly-A segments in the splenic cells of mice with virus-induced Rauscher leukemia].
    Smirnova IA; Nakonechnyĭ NV
    Vopr Med Khim; 1983; 29(6):63-9. PubMed ID: 6199896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct effects of adenine and guanine starvation on DNA synthesis associated with different pool sizes of nucleotide precursors.
    Duan DS; Sadée W
    Cancer Res; 1987 Aug; 47(15):4047-51. PubMed ID: 3496954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo.
    Mitchell BS; Koller CA; Heyn R
    Blood; 1980 Sep; 56(3):556-9. PubMed ID: 6967747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
    Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
    Wortmann RL; Mitchell BS; Edwards NL; Fox IH
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential incorporation of 2'-deoxyadenosine into human peripheral lymphocytes.
    Burgess FW; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1985 Sep; 34(18):3353-60. PubMed ID: 3929793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.